Literature DB >> 18652533

Multiple de novo mutations in the MECP2 gene.

David J Bunyan1, David O Robinson.   

Abstract

Rett syndrome is an X-linked dominant disorder that usually arises following a single de novo mutation in the MECP2 gene. Point mutation testing and gene dosage analysis of a cohort of British Rett syndrome patients in our laboratory revealed four females who each had two different de novo causative mutations, presumed to be in cis because the patients showed no deviation from the classical Rett syndrome phenotype. Two of these cases had a point mutation and a small intraexonic deletion, a third had a whole exon deletion and a separate small intraexonic deletion, and a fourth case had a small intraexonic deletion and a large duplication. These findings highlight the necessity to perform both point mutation analysis and exon dosage analysis in such cases, particularly because of the possibility of undetected parental mosaicism and the implications for prenatal diagnosis in future pregnancies. These cases also suggest that the MECP2 gene may be particularly prone to multiple mutation events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652533     DOI: 10.1089/gte.2008.0012

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  4 in total

Review 1.  De novo mutations in human genetic disease.

Authors:  Joris A Veltman; Han G Brunner
Journal:  Nat Rev Genet       Date:  2012-07-18       Impact factor: 53.242

2.  The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1.

Authors:  Holly N Cukier; Joycelyn M Lee; Deqiong Ma; Juan I Young; Vera Mayo; Brittany L Butler; Sandhya S Ramsook; Joseph A Rantus; Alexander J Abrams; Patrice L Whitehead; Harry H Wright; Ruth K Abramson; Jonathan L Haines; Michael L Cuccaro; Margaret A Pericak-Vance; John R Gilbert
Journal:  Autism Res       Date:  2012-10-10       Impact factor: 5.216

3.  Detection of rarely identified multiple mutations in MECP2 gene do not contribute to enhanced severity in Rett syndrome.

Authors:  Christopher A Chapleau; Jane Lane; Susan M Kirwin; Carolyn Schanen; Kathy M B Vinette; Danielle Stubbolo; Patrick MacLeod; Daniel G Glaze; Kathleen J Motil; Jeffrey L Neul; Steven A Skinner; Walter E Kaufmann; Alan K Percy
Journal:  Am J Med Genet A       Date:  2013-05-21       Impact factor: 2.802

4.  Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Front Synaptic Neurosci       Date:  2010-06-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.